Sevoflurane increases fade of neuromuscular response to TOF stimulation following rocuronium administration in children. A PK/PD analysis
- PMID: 17564645
- DOI: 10.1111/j.1460-9592.2006.02181.x
Sevoflurane increases fade of neuromuscular response to TOF stimulation following rocuronium administration in children. A PK/PD analysis
Abstract
Background: Sevoflurane enhances neuromuscular block produced by rocuronium, affecting not only single twitch response but also the response to high-frequency stimulation, increasing tetanic [or train-of-four (TOF)] fade.
Methods: We compared the degree of fade during spontaneous recovery from rocuronium-induced neuromuscular block in 24 children (3-11 years old, ASA groups I and II), anesthetized with nitrous oxide-sevoflurane (one MAC, endtidal concentration) or nitrous oxide-fentanyl. Neuromuscular transmission was monitored electromyographically (EMG), stimulating the ulnar nerve at the wrist with TOF, 2 Hz for 2 s, repeated at 20-s intervals and recording EMG potential from adductor pollicis brevis. Depression of the fourth twitch, T4, was used as a measure of fade. Following an intubating dose of rocuronium, 0.6 mgxkg(-1), continuous infusion of rocuronium was given to maintain stable 90-99% T1 depression. Plasma concentration of rocuronium was determined with high performance liquid chromatography with electrochemical detection (HPLC-EC) method at the moment of discontinuation of rocuronium infusion and 10, 20, 30, 40, 50, 60, and 75 min afterwards. A two compartment model was used for pharmacokinetic (PK) calculations. PK parameters were fixed and pharmacodynamic data were fitted to effect compartment model proposed by Sheiner.
Results: Sevoflurane reduced rocuronium concentration in effect compartment producing 50% inhibition of both T1 and T4 response and significantly delayed not only T1, but also T4 recovery.
Conclusions: Potentiating effect of sevoflurane on rocuronium-induced neuromuscular block influences not only postsynaptic, but also the presynaptic part of the neuromuscular junction, enhancing fade of neuromuscular response to high-frequency stimulation. The intensity of this latter effect is clinically relevant.
Similar articles
-
Pharmacokinetic-pharmacodynamic relationship of rocuronium under stable nitrous oxide-fentanyl or nitrous oxide-sevoflurane anesthesia in children.Paediatr Anaesth. 2006 Jul;16(7):761-8. doi: 10.1111/j.1460-9592.2005.01840.x. Paediatr Anaesth. 2006. PMID: 16879519 Clinical Trial.
-
Neuromuscular blocking effects of rocuronium during desflurane, isoflurane, and sevoflurane anaesthesia.Can J Anaesth. 1998 Jun;45(6):526-32. doi: 10.1007/BF03012702. Can J Anaesth. 1998. PMID: 9669005 Clinical Trial.
-
The influence of halothane, isoflurane and sevoflurane on rocuronium infusion in children.Acta Anaesthesiol Scand. 2001 Jan;45(1):73-7. doi: 10.1034/j.1399-6576.2001.450112.x. Acta Anaesthesiol Scand. 2001. PMID: 11152037 Clinical Trial.
-
Monitoring of neuromuscular transmission by electromyography during anaesthesia. A comparison with mechanomyography in cat and man.Dan Med Bull. 1996 Sep;43(4):301-16. Dan Med Bull. 1996. PMID: 8884132 Review.
-
Muscle relaxants: a clinical update.Acta Anaesthesiol Scand Suppl. 1996;109:165-7. Acta Anaesthesiol Scand Suppl. 1996. PMID: 8901994 Review.
Cited by
-
Research of medical gases in Poland.Med Gas Res. 2013 Aug 2;3(1):17. doi: 10.1186/2045-9912-3-17. Med Gas Res. 2013. PMID: 23916016 Free PMC article.
-
Population pharmacokinetic-pharmacodynamic analysis for sugammadex-mediated reversal of rocuronium-induced neuromuscular blockade.Br J Clin Pharmacol. 2011 Sep;72(3):415-33. doi: 10.1111/j.1365-2125.2011.04000.x. Br J Clin Pharmacol. 2011. PMID: 21535448 Free PMC article.
-
Mapping the current evidence on the anesthetic management of adult patients with neuromuscular disorders-a scoping review.Can J Anaesth. 2022 Jun;69(6):756-773. doi: 10.1007/s12630-022-02230-3. Epub 2022 Mar 23. Can J Anaesth. 2022. PMID: 35322378 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources